Libtayo (cemiplimab)

pCPA File Number: 21148
Negotiation Status:
Concluded with an LOI
Indication(s):
Cutaneous Squamous Cell Carcinoma
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
PC0187-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: